U.S. flag

An official website of the United States government

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Links from GEO Profiles

Items: 1 to 20 of 49

1.
Investigating VEGF. miR-145-3p, and miR-101-3p Expression in Patients with Cholangiocarcinoma
Maria Clara Jessica Calastri, Rafael Fernandes Ferreira, Graciele Domitila Tenani, Lucas Poleto Spinola, Gabriel Feltrin Vieira, Maria Filomena Rabaça Roque Botelho, Ana Margarida Coelho Abrantes, José Guilherme Lopes Rodrigues Tralhão, Ana Filipa Marques de Brito, Renato Ferreira da Silva, Rita de Cassia Martins Alves da Silva, Eliane Milharcix Zanovelo, Larissa Bastos Eloy da Costa, Danielle Caroline Brito de Souza, Dalisio de Santi Neto, Ilka de Fátima Santana Ferreira Boin, Dorotéia Rossi Silva Souza
Asian Pac J Cancer Prev. 2022 Jul; 23(7): 2233–2241. doi: 10.31557/APJCP.2022.23.7.2233
PMCID:
PMC9727337
AbstractArticlePDF–364K
2.
Transcription factor 3 (TCF3) combined with histone deacetylase 3 (HDAC3) down-regulates microRNA-101 to promote Burkitt lymphoma cell proliferation and inhibit apoptosis
Lihua Dong, Jingjing Huang, Peng Zu, Jing Liu, Xue Gao, Jianwei Du, Yufu Li
Bioengineered. 2021; 12(1): 7995–8005. Published online 2021 Oct 17. doi: 10.1080/21655979.2021.1977557
PMCID:
PMC8806859
AbstractArticlePDF–1.5M
3.
Hypoxic stress suppresses lung tumor-secreted exosomal miR101 to activate macrophages and induce inflammation
Jie Li, Peng Xu, Di Wu, Minjie Guan, Xuanwen Weng, Yongzhen Lu, Yuwei Zeng, Rongchang Chen
Cell Death Dis. 2021 Aug; 12(8): 776. Published online 2021 Aug 6. doi: 10.1038/s41419-021-04030-x
PMCID:
PMC8346509
AbstractArticlePDF–3.7M
4.
miR-101-3p Serves as a Tumor Suppressor for Renal Cell Carcinoma and Inhibits Its Invasion and Metastasis by Targeting EZH2
Yunze Dong, Yuchen Gao, Tiancheng Xie, Huan Liu, Xiangcheng Zhan, Yunfei Xu
Biomed Res Int. 2021; 2021: 9950749. Published online 2021 Jul 7. doi: 10.1155/2021/9950749
PMCID:
PMC8282380
AbstractArticlePDF–4.8M
5.
MicroRNA in combination with HER2-targeting drugs reduces breast cancer cell viability in vitro
Lisa Svartdal Normann, Miriam Ragle Aure, Suvi-Katri Leivonen, Mads Haugland Haugen, Vesa Hongisto, Vessela N. Kristensen, Gunhild Mari Mælandsmo, Kristine Kleivi Sahlberg
Sci Rep. 2021; 11: 10893. Published online 2021 May 25. doi: 10.1038/s41598-021-90385-2
PMCID:
PMC8149698
AbstractArticlePDF–2.0M
6.
Down-regulation of HCP5 inhibits cell proliferation, migration, and invasion through regulating EPHA7 by competitively binding miR-101 in osteosarcoma
Yangmao Tu, Qing Cai, Xuemei Zhu, Min Xu
Braz J Med Biol Res. 2021; 54(2): e9161. Published online 2021 Jan 8. doi: 10.1590/1414-431X20209161
PMCID:
PMC7798137
AbstractArticlePDF–1.1M
7.
lncRNA SNHG1 attenuates osteogenic differentiation via the miR-101/DKK1 axis in bone marrow mesenchymal stem cells
Jie Xiang, Hai-Qing Fu, Zhun Xu, Wei-Jie Fan, Fei Liu, Bin Chen
Mol Med Rep. 2020 Nov; 22(5): 3715–3722. Published online 2020 Sep 2. doi: 10.3892/mmr.2020.11489
PMCID:
PMC7533455
AbstractArticlePDF–1.6M
8.
RNA‐sequence‐based microRNA expression signature in breast cancer: tumor‐suppressive miR‐101‐5p regulates molecular pathogenesis
Hiroko Toda, Naohiko Seki, Sasagu Kurozumi, Yoshiaki Shinden, Yasutaka Yamada, Nijiro Nohata, Shogo Moriya, Tetsuya Idichi, Kosei Maemura, Takaaki Fujii, Jun Horiguchi, Yuko Kijima, Shoji Natsugoe
Mol Oncol. 2020 Feb; 14(2): 426–446. Published online 2019 Dec 29. doi: 10.1002/1878-0261.12602
PMCID:
PMC6998431
AbstractArticlePDF–7.0M
9.
The upregulation of miR-101 promotes vascular endothelial cell apoptosis and suppresses cell migration in acute coronary syndrome by targeting CDH5
Simin Cao, Li Li, Xuebin Geng, Yi Ma, Xu Huang, Xiaoli Kang
Int J Clin Exp Pathol. 2019; 12(9): 3320–3328. Published online 2019 Sep 1.
PMCID:
PMC6949823
AbstractArticlePDF–1.4M
10.
MicroRNA-101a Regulates Autophagy Phenomenon via the MAPK Pathway to Modulate Alzheimer’s-Associated Pathogenesis
Qian Li, Yu Wang, Wenjie Peng, Yanjie Jia, Jinhua Tang, Wanwei Li, John H. Zhang, Jun Yang
Cell Transplant. 2019 Aug; 28(8): 1076–1084. Published online 2019 Jun 17. doi: 10.1177/0963689719857085
PMCID:
PMC6728707
AbstractArticlePDF–753K
11.
Increased Expression of Circulating microRNA 101-3p in Type 1 Diabetes Patients: New Insights Into miRNA-Regulated Pathophysiological Pathways for Type 1 Diabetes
Aritania S. Santos, Edecio Cunha Neto, Rosa T. Fukui, Ludmila R. P. Ferreira, Maria Elizabeth R. Silva
Front Immunol. 2019; 10: 1637. Published online 2019 Jul 23. doi: 10.3389/fimmu.2019.01637
PMCID:
PMC6665278
AbstractArticlePDF–1.4M
12.
HIV-1 Tat C Modulates Expression of miRNA-101 to Suppress VE-Cadherin in Human Brain Microvascular Endothelial Cells
Ritu Mishra, Sunit Kumar Singh
J Neurosci. 2013 Apr 3; 33(14): 5992–6000. doi: 10.1523/JNEUROSCI.4796-12.2013
PMCID:
PMC6618916
AbstractArticlePDF–1.1M
13.
miR-101 suppresses the development of MLL-rearranged acute myeloid leukemia
Estrella Gonzales-Aloy, Patrick Connerty, Basit Salik, Bing Liu, Andrew J. Woo, Michelle Haber, Murray D. Norris, Jianlong Wang, Jenny Y. Wang
Haematologica. 2019 Jul; 104(7): e296–e299. doi: 10.3324/haematol.2018.209437
PMCID:
PMC6601101
ArticlePDF–1.3M
14.
miR‐101 Acts as a Tumor Suppressor by Targeting Kruppel‐like Factor 6 in Glioblastoma Stem Cells
Yi‐Long Yao, Jun Ma, Ping Wang, Yi‐Xue Xue, Zhen Li, Li‐Ni Zhao, Zhi‐Qing Li, Tian‐Da Feng, Yun‐Hui Liu
CNS Neurosci Ther. 2015 Jan; 21(1): 40–51. Published online 2014 Sep 17. doi: 10.1111/cns.12321
PMCID:
PMC6495804
AbstractArticlePDF–1.4M
15.
The proliferation and invasion of osteosarcoma are inhibited by miR-101 via targetting ZEB2
Haopeng Lin, Xiaodong Zheng, Ting Lu, Yang Gu, Canhao Zheng, Huajie Yan
Biosci Rep. 2019 Feb 28; 39(2): BSR20181283. Prepublished online 2019 Jan 28. Published online 2019 Feb 8. doi: 10.1042/BSR20181283
PMCID:
PMC6367128
AbstractArticlePDF–1.0M
16.
O-GlcNAcylation promotes colorectal cancer metastasis via the miR-101-O-GlcNAc/EZH2 regulatory feedback circuit
Mingzuo Jiang, Bing Xu, Xiaowei Li, Yulong Shang, Yi Chu, Weijie Wang, Di Chen, Nan Wu, Sijun Hu, Song Zhang, Mengbin Li, Kaichun Wu, Xiaoyong Yang, Jie Liang, Yongzhan Nie, Daiming Fan
Oncogene. 2019; 38(3): 301–316. Published online 2018 Aug 9. doi: 10.1038/s41388-018-0435-5
Correction in:
Oncogene. 2019; 38(28): 5744–5745.
PMCID:
PMC6336687
AbstractArticlePDF–4.8M
17.
LncRNA PTAR promotes EMT and invasion-metastasis in serous ovarian cancer by competitively binding miR-101-3p to regulate ZEB1 expression
Haihai Liang, Tong Yu, Yue Han, Hua Jiang, Chengyu Wang, Tianyi You, Xiaoguang Zhao, Huitong Shan, Rui Yang, Lida Yang, Hongli Shan, Yunyan Gu
Mol Cancer. 2018; 17: 119. Published online 2018 Aug 11. doi: 10.1186/s12943-018-0870-5
Correction in:
Mol Cancer. 2021; 20: 64.
PMCID:
PMC6087007
AbstractArticlePDF–3.0M
18.
A Nucleolar Stress–Specific p53–miR-101 Molecular Circuit Functions as an Intrinsic Tumor-Suppressor Network
Yuko Fujiwara, Motonobu Saito, Ana I. Robles, Momoyo Nishida, Fumitaka Takeshita, Masatoshi Watanabe, Takahiro Ochiya, Jun Yokota, Takashi Kohno, Curtis C. Harris, Naoto Tsuchiya
EBioMedicine. 2018 Jul; 33: 33–48. Published online 2018 Jul 7. doi: 10.1016/j.ebiom.2018.06.031
PMCID:
PMC6085539
AbstractArticlePDF–4.3M
19.
PTBP1 enhances miR-101-guided AGO2 targeting to MCL1 and promotes miR-101-induced apoptosis
Jia Cui, William J. Placzek
Cell Death Dis. 2018 May; 9(5): 552. Published online 2018 May 10. doi: 10.1038/s41419-018-0551-8
PMCID:
PMC5945587
AbstractArticlePDF–1.0M
20.
Identification of the novel 3′ UTR sequences of human IL-21 mRNA as potential targets of miRNAs
Yutaka Enomoto, Rie Takagi, Yutaka Naito, Tsuyoshi Kiniwa, Yasuhito Tanaka, Susumu Hamada-Tsutsumi, Masaaki Kawano, Sho Matsushita, Takahiro Ochiya, Atsushi Miyajima
Sci Rep. 2017; 7: 7780. Published online 2017 Aug 10. doi: 10.1038/s41598-017-07853-x
PMCID:
PMC5552845
AbstractArticlePDF–1.3M

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Filter your results:

Find related data

Recent activity

You are here: NCBI > Literature > PubMed Central (PMC)
Support Center